Literature DB >> 31395346

Epigenetic regulation of DNA repair genes and implications for tumor therapy.

Markus Christmann1, Bernd Kaina2.   

Abstract

DNA repair represents the first barrier against genotoxic stress causing metabolic changes, inflammation and cancer. Besides its role in preventing cancer, DNA repair needs also to be considered during cancer treatment with radiation and DNA damaging drugs as it impacts therapy outcome. The DNA repair capacity is mainly governed by the expression level of repair genes. Alterations in the expression of repair genes can occur due to mutations in their coding or promoter region, changes in the expression of transcription factors activating or repressing these genes, and/or epigenetic factors changing histone modifications and CpG promoter methylation or demethylation levels. In this review we provide an overview on the epigenetic regulation of DNA repair genes. We summarize the mechanisms underlying CpG methylation and demethylation, with de novo methyltransferases and DNA repair involved in gain and loss of CpG methylation, respectively. We discuss the role of components of the DNA damage response, p53, PARP-1 and GADD45a on the regulation of the DNA (cytosine-5)-methyltransferase DNMT1, the key enzyme responsible for gene silencing. We stress the relevance of epigenetic silencing of DNA repair genes for tumor formation and tumor therapy. A paradigmatic example is provided by the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT), which is silenced in up to 40% of various cancers through CpG promoter methylation. The CpG methylation status of the MGMT promoter strongly correlates with clinical outcome and, therefore, is used as prognostic marker during glioblastoma therapy. Mismatch repair genes are also subject of epigenetic silencing, which was shown to correlate with colorectal cancer formation. For many other repair genes shown to be epigenetically regulated the clinical outcome is not yet clear. We also address the question of whether genotoxic stress itself can lead to epigenetic alterations of genes encoding proteins involved in the defense against genotoxic stress.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer therapy; DNA repair; Epigenetic silencing; GADD45; Genotoxic stress; MGMT; Promoter methylation; TET; p53; tumor formation

Mesh:

Year:  2017        PMID: 31395346     DOI: 10.1016/j.mrrev.2017.10.001

Source DB:  PubMed          Journal:  Mutat Res Rev Mutat Res        ISSN: 1383-5742            Impact factor:   5.657


  19 in total

Review 1.  Role of Mitochondria in Radiation Responses: Epigenetic, Metabolic, and Signaling Impacts.

Authors:  Dietrich Averbeck; Claire Rodriguez-Lafrasse
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

Review 2.  DNA methylation in pulmonary fibrosis and lung cancer.

Authors:  Juan Duan; Baiyun Zhong; Zhihua Fan; Hao Zhang; Mengmeng Xu; Xiangyu Zhang; Yan Y Sanders
Journal:  Expert Rev Respir Med       Date:  2022-06-08       Impact factor: 4.300

3.  Fun30 and Rtt109 Mediate Epigenetic Regulation of the DNA Damage Response Pathway in C. albicans.

Authors:  Prashant Kumar Maurya; Pramita Garai; Kaveri Goel; Himanshu Bhatt; Anindita Dutta; Aarti Goyal; Sakshi Dewasthale; Meghna Gupta; Dominic Thangminlen Haokip; Sanju Barik; Rohini Muthuswami
Journal:  J Fungi (Basel)       Date:  2022-05-25

4.  Temozolomide - Just a Radiosensitizer?

Authors:  Bernd Kaina; Lea Beltzig; Herwig Strik
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

Review 5.  Epigenetic Mechanisms in DNA Double Strand Break Repair: A Clinical Review.

Authors:  Alejandra Fernandez; Connor O'Leary; Kenneth J O'Byrne; Joshua Burgess; Derek J Richard; Amila Suraweera
Journal:  Front Mol Biosci       Date:  2021-07-07

6.  Host proteome linked to HPV E7-mediated specific gene hypermethylation in cancer pathways.

Authors:  Nopphamon Na Rangsee; Pattamawadee Yanatatsaneejit; Trairak Pisitkun; Poorichaya Somparn; Pornrutsami Jintaridth; Supachai Topanurak
Journal:  Infect Agent Cancer       Date:  2020-02-03       Impact factor: 2.965

7.  Methylated CpG dinucleotides in the 5-α reductase 2 gene may explain finasteride resistance in benign prostatic enlargement patients.

Authors:  Zhe-Min Lin; Dong-Dong Fan; Song Jin; Zhan-Liang Liu; Yi-Nong Niu
Journal:  Asian J Androl       Date:  2021 May-Jun       Impact factor: 3.285

Review 8.  Dissecting Molecular Features of Gliomas: Genetic Loci and Validated Biomarkers.

Authors:  Antonietta Arcella; Fiona Limanaqi; Rosangela Ferese; Francesca Biagioni; Maria Antonietta Oliva; Marianna Storto; Mirco Fanelli; Stefano Gambardella; Francesco Fornai
Journal:  Int J Mol Sci       Date:  2020-01-20       Impact factor: 5.923

9.  Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells.

Authors:  Bernd Kaina; Lea Beltzig; Andrea Piee-Staffa; Bodo Haas
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

Review 10.  Targeting DNA Damage Response in Prostate and Breast Cancer.

Authors:  Antje M Wengner; Arne Scholz; Bernard Haendler
Journal:  Int J Mol Sci       Date:  2020-11-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.